These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

322 related articles for article (PubMed ID: 29793867)

  • 1. Heart Rate, Responsiveness to Intravenous Immunoglobulin, and Coronary Artery Aneurysms in Kawasaki Disease.
    Miyakoshi C; Yamamoto Y; Yamakawa M; Fukuhara S
    J Pediatr; 2018 Sep; 200():160-165.e5. PubMed ID: 29793867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H; He Y; Rong X; Ren Y; Pan L; Chu M; Wu R; Shi H
    Postgrad Med; 2018 May; 130(4):442-447. PubMed ID: 29745742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Coronary Artery Aneurysms in Kawasaki Disease: Risk Factors for Progressive Disease and Adverse Cardiac Events in the US Population.
    Friedman KG; Gauvreau K; Hamaoka-Okamoto A; Tang A; Berry E; Tremoulet AH; Mahavadi VS; Baker A; deFerranti SD; Fulton DR; Burns JC; Newburger JW
    J Am Heart Assoc; 2016 Sep; 5(9):. PubMed ID: 27633390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease in Turkish children: a single center experience with emphasis on intravenous immunoglobulin resistance and giant coronary aneurysms.
    Yılmazer MM; Özdemir R; Meşe T; Küçük M; Öner T; Devrim İ; Bayram N; Güven B; Tavlı V
    Turk J Pediatr; 2019; 61(5):648-656. PubMed ID: 32104995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with development of coronary artery aneurysms after Kawasaki disease are similar for those treated promptly and those with delayed or no treatment.
    Downie ML; Manlhiot C; Collins TH; Chahal N; Yeung RSM; McCrindle BW
    Int J Cardiol; 2017 Jun; 236():157-161. PubMed ID: 28089146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infliximab Plus Intravenous Immunoglobulin (IVIG) Versus IVIG Alone as Initial Therapy in Children With Kawasaki Disease Presenting With Coronary Artery Lesions: Is Dual Therapy More Effective?
    Jone PN; Anderson MS; Mulvahill MJ; Heizer H; Glodé MP; Dominguez SR
    Pediatr Infect Dis J; 2018 Oct; 37(10):976-980. PubMed ID: 29461447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Development of Coronary Artery Aneurysm in Patients with Kawasaki Disease Who Were Clinically Responsive to Immunoglobulin.
    Matsuoka R; Furuno K; Nanishi E; Onoyama S; Nagata H; Yamamura K; Sugitani Y; Kuraoka A; Mizuno Y; Sagawa K; Honjo S; Hara T; Ohga S
    J Pediatr; 2020 Dec; 227():224-230.e3. PubMed ID: 32810506
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of intravenous immunoglobulin plus prednisolone therapy in patients with Kawasaki disease (Post RAISE): a multicentre, prospective cohort study.
    Miyata K; Kaneko T; Morikawa Y; Sakakibara H; Matsushima T; Misawa M; Takahashi T; Nakazawa M; Tamame T; Tsuchihashi T; Yamashita Y; Obonai T; Chiga M; Hori N; Komiyama O; Yamagishi H; Miura M;
    Lancet Child Adolesc Health; 2018 Dec; 2(12):855-862. PubMed ID: 30337183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk Factors of Coronary Artery Aneurysms in Kawasaki Disease with a Low Risk of Intravenous Immunoglobulin Resistance: An Analysis of Post RAISE.
    Iio K; Morikawa Y; Miyata K; Kaneko T; Misawa M; Yamagishi H; Miura M
    J Pediatr; 2022 Jan; 240():158-163.e4. PubMed ID: 34461064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of serum lipid in predicting coronary artery lesions and intravenous immunoglobulin resistance in Kawasaki disease: a cohort study.
    Zhang H; Cai J; Zhang R; Shuai S; Tang M; Ju R; Hu Y; Zuo T; Yang Y
    J Int Med Res; 2024 May; 52(5):3000605241252115. PubMed ID: 38713460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Response of refractory Kawasaki disease to intravenous methylprednisolone.
    Shah I; Prabhu SS
    Ann Trop Paediatr; 2009 Mar; 29(1):51-3. PubMed ID: 19222935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Retrospective Cohort Study of Intravenous Immunoglobulin Therapy in the Acute Phase of Kawasaki Disease: The Earlier, the Better?
    Li W; He X; Zhang L; Wang Z; Wang Y; Lin H; Yuan J; Xie X; Qin Y; Huang P
    Cardiovasc Ther; 2021; 2021():6660407. PubMed ID: 34239607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inability of Asian risk scoring systems to predict intravenous immunoglobulin resistance and coronary lesions in Kawasaki disease in an Italian cohort.
    Fabi M; Andreozzi L; Corinaldesi E; Bodnar T; Lami F; Cicero C; Tchana B; Landini C; Sprocati M; Bigucci B; Balsamo C; Sogno Valin P; Di Fazzio G; Iughetti L; Valletta E; Marchetti F; Donti A; Lanari M
    Eur J Pediatr; 2019 Mar; 178(3):315-322. PubMed ID: 30499051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Severity of Coronary Artery Aneurysms in Patients With Kawasaki Disease and Risk of Later Coronary Events.
    Miura M; Kobayashi T; Kaneko T; Ayusawa M; Fukazawa R; Fukushima N; Fuse S; Hamaoka K; Hirono K; Kato T; Mitani Y; Sato S; Shimoyama S; Shiono J; Suda K; Suzuki H; Maeda J; Waki K; ; Kato H; Saji T; Yamagishi H; Ozeki A; Tomotsune M; Yoshida M; Akazawa Y; Aso K; Doi S; Fukasawa Y; Furuno K; Hayabuchi Y; Hayashi M; Honda T; Horita N; Ikeda K; Ishii M; Iwashima S; Kamada M; Kaneko M; Katyama H; Kawamura Y; Kitagawa A; Komori A; Kuraishi K; Masuda H; Matsuda S; Matsuzaki S; Mii S; Miyamoto T; Moritou Y; Motoki N; Nagumo K; Nakamura T; Nishihara E; Nomura Y; Ogata S; Ohashi H; Okumura K; Omori D; Sano T; Suganuma E; Takahashi T; Takatsuki S; Takeda A; Terai M; Toyono M; Watanabe K; Watanabe M; Yamamoto M; Yamamura K
    JAMA Pediatr; 2018 May; 172(5):e180030. PubMed ID: 29507955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Importance of C-reactive protein level in predicting non-response to additional intravenous immunoglobulin treatment in children with Kawasaki disease: a retrospective study.
    Iwashima S; Kimura M; Ishikawa T; Ohzeki T
    Clin Drug Investig; 2011; 31(3):191-9. PubMed ID: 21456105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of the Egami Score in Predicting Intravenous Immunoglobulin Resistance in Kawasaki Disease Among Different Ethnicities.
    Loomba RS; Raskin A; Gudausky TM; Kirkpatrick E
    Am J Ther; 2016; 23(6):e1293-e1299. PubMed ID: 25611359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hibiscus score: Developing and validating a predictive tool for intravenous immunoglobulin treatment resistance in Malaysian children with Kawasaki disease.
    Tan JYC; Ng SY; Chan HK; Wong PM; Mohamed Zabidi H; Abu Hassan MR
    J Cardiol; 2024 Dec; 84(6):362-365. PubMed ID: 38852775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Clinical Utility and Safety of a New Strategy for the Treatment of Refractory Kawasaki Disease.
    Ebato T; Ogata S; Ogihara Y; Fujimoto M; Kitagawa A; Takanashi M; Ishii M
    J Pediatr; 2017 Dec; 191():140-144. PubMed ID: 29173297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of Coronary Artery Abnormalities with Fever Pattern in Patients with Kawasaki Disease.
    Tanaka A; Inoue M; Hoshina T; Koga H
    J Pediatr; 2021 Sep; 236():95-100. PubMed ID: 34019881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Harada score in the US population of children with Kawasaki disease.
    Tewelde H; Yoon J; Van Ittersum W; Worley S; Preminger T; Goldfarb J
    Hosp Pediatr; 2014 Jul; 4(4):233-8. PubMed ID: 24986993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.